Summary
The administration of the 5-HT1A agonist 8-OH-DPAT, 0.1 mg kg−1 sc −20 min, produced a moderate suppression of conditioned avoidance behavior (60% of controls) in the rat. This effect, however, was not seen after administration of higher doses, 0.4 and 1.6 mg kg−1 sc. The number of intertriai crosses were not affected by the lower dose but significantly increased by administration of the two higher doses of 8-OH-DPAT. The dopamine D2 receptor blocking agent raclopride, 0.05 mg kg−1, by itself did not suppress the avoidance behavior, but in combination with 8-OH-DPAT produced suppression of avoidance behavior (30% of controls) as well as intertrial crosses. Open field locomotor activity was suppressed by raclopride, 0.1 mg kg−1 sc, or by 8-OH-DPAT, 0.1 mg kg−1 sc. The combined treatment produced a further suppression of locomotor activity and a marked increase in “immobility” (stationary movements). Treadmill locomotion, however, was not affected by either compound by itself, whereas the combined treatment impaired treadmill performance. Suppression of treadmill performance by a higher dose of raclopride, 0.4 mg kg−1 sc, was not altered by the additional treatment with 8-OH-DPAT, 0.1 mg kg−1. In contrast to the additive effects of 8-OH-DPAT and raclopride on conditioned avoidance behavior, open field locomotion and treadmill performance, the catalepsy produced by raclopride, 16 mg kg−1 was completely antagonised by treatment with 8-OH-DPAT 0.1 mg kg−1. Taken together, the present findings demonstrate strong interactions between a 5-HT agonist and a DA D2 antagonist on some critical tests for antipsychotic-like actions and extrapyramidal motor effects in rats, and suggest new possibilities in the search for new antipsychotic drugs with higher clinical efficacy and less extrapyramidal side effects
Similar content being viewed by others
References
Ahlenius S, Archer T, Tandberg B, Hillegaart V (1984) Effects of (−)3-PPP on aquisition and retention of a conditioned avoidance response in the rat. Psychopharmacology 84: 441–445
Ahlenius S, Larsson K (1985) Antagonism by lisuride and 8-OH-DPAT of 5-HTP-induced prolongation of the performance of male rat sexual behavior. Eur J Pharmacol 110: 379–381
Ahlenius S, Hillegaart V (1986) Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 24: 1409–1415
Ahlenius S, Hillegaart V, Wijkström A (1989) Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat. Naunyn Schmiedebergs Arch Pharmacol 339: 551–556
Andén N-E, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11: 303–314
Balsara JJ, Jadhav JH, Chandorka AG (1979) Effects of drugs influencing central serotonergic mechanisms of haloperidol-induced catalepsy. Psychopharmacology 62: 67–69
Broekkamp RW, Cervo SK, Berendsen HHG, van Delft AML (1988) Effect of metergoline, fenfluramine and 8-OH-DPAT on catalepsy induced by haloperidol or morphine. Naunyn Schmiedebergs Arch Pharmacol 338: 191–195
Carlsson M, Eriksson E (1986) A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats. Pharmacol Toxicol 58: 297–302
Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P (1983) The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology 81: 14–17
Creese I (1987) Biochemical properties of CNS dopamine receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 257–264
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105: 365–368
Fuenmayor LD, Vogt M (1979) The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics. Br J Pharmacol 67: 309–318
Gumulka W, Kostowski W, Czlonkowski A (1973) Role of 5-HT in the action of some drugs affecting extrapyramidal system. Pharmacology 10: 363–372
Hillegaart V, Ahlenius S (1987) Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behavior and catalepsy in rats: behavioral profile comparisons between raclopride, haloperidol and preclamol. Pharmacol Toxicol 60: 350–354
Hillegaart V, Wadenberg M-L, Ahlenius S (1989) Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol Biochem Behav 32: 797–800
Hillegaart V, Hjorth S, Ahlenius S (1989) Regional forebrain 5-HT synthesis after local application of 5-HT or 8-OH-DPAT into the dorsal (DR) or median (MR) raphe nucleus of the rat. Eur J Neurosci S2: 196
Hillegaart V, Hjorth S, Ahlenius S (1990) Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J Neural Transm [GenSect] 81: 131–145
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity. J Neural Transm 55: 169–188
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81: 89–99
Hjorth S, Magnusson T (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 338: 463–471
Invernizzi RW, Cervo L, Samanin R (1988) 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology 27: 515–518
Kostowski W, Gumulka W, Czlonkowski A (1972) Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated withp-chlorophenylalanine. Brain Res 48: 443–446
Köhler C, Hall H, ögren S-O, Gawell L (1985) Specific in vitro and in vivo binding of [3 H]-raclopride. A potent substituted benzamide drug with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34: 2251–2259
Li CC (1964) Introduction to experimental statistics. Mc Graw-Hill, New York, pp 207–226
McMillen BA (1985) Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. J Neural Transm 64: 1–12
McMillen BA, Scott SM, Davanzo EA (1988) Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. J Pharm Pharmacol 40: 885–887
Middlemiss DN, Fozard JR. (1983) 8-hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 30: 151–153
Mittmann SM, Geyer MA (1989) Effects of 5-HT1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology 98: 321–329
Palacios JM, Pazos A, Hoyer D (1987) Characterization and mapping of 5-HT1A sites in the brain of animals and man. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors. Ellis Horwood, Chichester, pp 67–81
Siegel S (1988) Nonparametric statitics for the behavioral sciences. McGraw-Hill, New York
Wadenberg M-L, Ahlenius S (1988) Suppression of conditioned avoidance by 8-OH-DPAT in the rat. J Neural Transm 74: 195–198
Waldmeier PC, Delini-Stula AA (1979) Serotonin-dopamine interactions in the nigrostriatal system. Eur J Pharmacol 55: 363–373
Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wadenberg, M.L., Ahlenius, S. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J. Neural Transmission 83, 43–53 (1991). https://doi.org/10.1007/BF01244451
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244451